Skip to main content
Log in

Leberfunktion von Patienten mit arterieller Hypoxämie bei chronisch obstruktiver Atemwegserkrankung und der Einfluß der nasalen Sauerstoffinsufflation

Liver function in patients with arterial hypoxemia and chronic obstructive airway disease and the influence of nasal oxygen insufflation

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Patients suffering from chronic obstructive airway disease often have arterial hypoxemia, which is more or less severe. If hypoxemia deteriorates the function of the liver is still unknown. The aim of this study was to determine, if a mostly oxygen dependent process of liver metabolism (galactose elimination capacity) is disturbed and if it can be increased by oxygen insufflation. Under the same conditions an oxygen independent process (indocyaninegreen clearance) should not be influenced. Our results show, that galactose elimination capacity under room air was pathologic and can be increased significantly by oxygen breathing. No change of indocyaninegreen clearance was seen under the same conditions. After termination of oxygen therapy the galactose elimination capacity was as bad as before oxygen breathing. Dysfunctions of the liver, which are caused by hypoxemia, can be positively influenced by oxygen, but only for the duration of oxygen insufflation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Adm:

Mitteldruck im rechten Vorhof

CHE:

Cholinesterase

Gamma-GT:

Gamma-Glutamyl-Transferase

GEK:

Galaktose-Eliminations-Kapazität

ICG-HWZ:

Indocyaningrün-Halbwertzeit

KG:

Körpergewicht

NAD:

Nicotinsäureamid

NADH2 :

reduziertes Nicotinsäureamid

O2 :

molekularer Sauerstoff

pCO2a :

arterieller Kohlensäurepartialdruck

pO2a :

arterieller Sauerstoffpartialdruck

SGOT:

Serum-Glutamat-Oxalacetat-Transaminase

SGPT:

Serum-Glutamat-Pyruvat-Transaminase

SO2a :

arterielle Sauerstoffsättigung

Literatur

  • Bär U, Schroeter U, Schmidt FW (1970) A combined liver function test with bromsulfalein, indocyanine green and galactose. Eur J clin Invest 1:125–126

    Google Scholar 

  • Caesar J, Shaldon S, Chiandussi L (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21:43–57

    Google Scholar 

  • Cooke AR, Harrison DD, Skyring AP (1963) Use of indocyanine green as a test of liver function. Amer J dig Dis 8:244–250

    Google Scholar 

  • Forsander OA (1966) The galactose tolerance test as a measurement of the redox potential of the liver. Scand J clin Lab Invest 18:143–144

    Google Scholar 

  • Fox LJ, Brooker LGS, Heseltine DW (1957) A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Mayo Clin Proc 32:478–484

    Google Scholar 

  • Henning R, Knodel W (1969) Die intravenöse Galaktose-Belastung. Enzymatische Substratbestimmung im Kapillarblut. Med Welt 20:7–9

    Google Scholar 

  • Hunton DP, Bollman JL, Hoffman HN (1960) Studies of hepatic function with indocyanine green. Gastroenterology 39:713–724

    Google Scholar 

  • Isselbacher KJ, Krane SM (1959) Studies on the mechanism of the inhibition of galactose oxydation by ethanol. J Bio Chem 236:2394–2398

    Google Scholar 

  • Kuntz HD, May B (1983) Veränderungen der Leberfunktion bei Schockleber und akuter Stauungsleber. Intensivmed 20:17–20

    Google Scholar 

  • Kuntz HD, Matthes U, Reitemeyer E, Tönissen R, May B (1987) Leber und Herz. Med Welt 38:1410–1415

    Google Scholar 

  • Leevy CM, Mendenhall CL, Lesko W, Howard MM (1962) Estimation of hepatic blood flow with indocyanine green. J clin Invest 41:1169–1179

    Google Scholar 

  • Leevy CM, Bendorf J, Silverberg M, Naylor J (1963) Physiology of dye extraction by the liver: comparative studies of sulfobromophthalin and indocyanine green. Ann N Y Acad Sci 111:161–175

    Google Scholar 

  • Leevy CM, Smith F, Longueville J (1977) Indocyanine green clearance as a test for hepatic function. J Amer med Ass 200:236–240

    Google Scholar 

  • Leevy CM, Leevy CB, Howard MM (1979) Indocyanine green and the liver. In: Davidson CS (ed) Problems in liver diseases. Thieme, Stuttgart New York, pp 42–52

    Google Scholar 

  • Liehr H (1982) Die Bedeutung der Leber und des RES im Schock. Hämostaseologie 2:68–72

    Google Scholar 

  • Nilsson LH, Hultman E (1974) A comparison of the bromsulphthalein and galactose elimination test in patients either with chronic bowel inflammation or alcoholic liver disease. Scand J Gastroent 9:319–323

    Google Scholar 

  • Paumgartner G (1975) The handling of indocyanine green by the liver. Schweiz med Wschr, Suppl 105:5–30

    Google Scholar 

  • Salaspuro MP, Kesaniemi YA (1973) Intravenous galactose elimination test with and without ethanol loading in various clinical conditions. Scand J Gastroent 8:681–686

    Google Scholar 

  • Schött D, Kuntz HD, Höltmann B, Straub H (1984) Der Einfluß der nasalen Sauerstoffinsufflation auf die Galaktose-Eliminationskapazität der Leber bei Patienten mit chronisch obstruktiver Atemwegserkrankung und respiratorischer Insuffizienz. Atemw Lungenkrkh 10:395–398

    Google Scholar 

  • Tengström B (1966) An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic acids in hepatobiliary diseases. Scand J clin Lab Invest 18, Suppl 92:132–142

    Google Scholar 

  • Tengström B (1968) An intravenous galactose tolerance test and its use in hepatobiliary diseases. Acta med scand 183:31–40

    Google Scholar 

  • Tengström B (1969) The discriminatory ability of a galactose tolerance test and some other tests in the diagnosis of cirrhosis of the liver, hepatitis and biliary obstruction. Scand J clin Lab Invest 23:159–168

    Google Scholar 

  • Tygstrup N, Winkler K (1954) Kinetics of galactose elimination. Acta physiol scand 32:354–362

    Google Scholar 

  • Tygstrup N, Winkler K (1958) Galactose blood clearancae as a measure of hepatic blood flow. Clin Sci 17:1–9

    Google Scholar 

  • Tygstrup N (1964a) The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta med scand 175:281–290

    Google Scholar 

  • Tygstrup N (1964b) The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta med scand 175:291–300

    Google Scholar 

  • Tygstrup N (1966) Determination of the hepatic elimination capacity of galactose by single injection. Scand J clin Lab Invest 18:118–125

    Google Scholar 

  • Villeneuve JP (1982) The estimation of hepatic blood blow with indocyanine green: Comparison between the continuous infusion and single injection methods. Amer J Gastroent 77:233–238

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Micklefield, G.H., Schött, D., Kuntz, H.D. et al. Leberfunktion von Patienten mit arterieller Hypoxämie bei chronisch obstruktiver Atemwegserkrankung und der Einfluß der nasalen Sauerstoffinsufflation. Klin Wochenschr 67, 833–838 (1989). https://doi.org/10.1007/BF01725200

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01725200

Key words

Navigation